Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="FERSTER, A" or (type any "bookEditor issueEditor" and editor="FERSTER, A")

Add to list
- Conference Paper
- C3
Reversion of Autoimmune Lymphoproliferative Syndrome with an anti malaria drug: Clinical and molecular observations

JEV TEN BOSCH, P SCHOTTE, A FERSTER, C DEMANET, R BEYAERT, Genevieve Laureys (UGent) , K THIELEMANS and J OTTEN

(2000) BLOOD. 96(11).
Add to list
- Journal Article
- A1
Treatment outcome in infant acute lymphoblastic leukemia.

A FERSTER, Yves Benoit, N FRANCOTTE, MF DRESSE, A UYTTEBROECK, E PLOUVIER, A THYSS, P LUTZ, G MARGUERITE, C BEHAR, et al.

(2000) BLOOD. 95(8). p.2729-2730
Add to list
- Journal Article
- A1
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 Randomized Phase III Trial.

F MILLOT, S SUCIU, N PHILIPPE, Yves Benoit, F MAZINGUE, A UYTTEBROECK, P LUTZ, F MECHINAUD, A ROBERT, P BOUTARD, et al.

(2000) JOURNAL OF CLINICAL ONCOLOGY. 19(7). p.1935-1942
Add to list
- Journal Article
- A1
Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report.

E VILMER, S SUCIU, A FERSTER, Y BERTRAND, H CAVÉ, A THYSS, Yves Benoit, N DASTUGUE, M FOURNIER, G SOUILLET, et al.

(2000) LEUKEMIA. 14(12). p.2257-2266
Add to list
P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia : results of a 6-year prospective study

Catharina Dhooge (UGent) , Barbara De Moerloose (UGent) , Genevieve Laureys (UGent) , Jozef Kint, A Ferster, Dirk De Bacquer (UGent) , Jan Philippé (UGent) and Yves Benoit

(1999) BRITISH JOURNAL OF HAEMATOLOGY. 105(3). p.676-683
Add to list
- Journal Article
- A1
The Belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor

MF DRESSE, M BOOGAERTS, C VERMYLEN, L NOENS, A FERRANT, R SCHOTS, C DOYEN, D BRON, Z BERNEMAN, A FERSTER, et al.

(1999) HAEMATOLOGICA. 84(7). p.637-642
Add to list
- Journal Article
- A1
Hematopoietic stem cell transplantation in sickle-cell anemia.

G CORNU, C VERMYLEN, A FERSTER, B BRICHARD, J NINANE, A FERRANT, A ZENEBERGH, P MAES, Catharina Dhooge (UGent) , Yves Benoit, et al.

(1999) Archives de pédiatrie.
Add to list
- Conference Paper
- C3
Primary immune deficiencies in Belgium.

CM FARBER, K BOVEN, Frans De Baets (UGent) , A FERSTER, C HOYOUX, F MASCART-LEMONE, P PHILIPPET, JP VAN VOOREN and C VERMIJLEN

(1998) MOLECULAR IMMUNOLOGY. 35(11-12). p.791-791
Add to list
- Journal Article
- A1
Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.

C VERMYLEN, G CORNU, A FERSTER, B BRICHARD, J NINANE, A FERRANT, A ZENEBERGH, P MAES, Catharina Dhooge (UGent) , Yves Benoit, et al.

(1998) BONE MARROW TRANSPLANTATION. 22(1). p.1-6
Add to list
- Journal Article
- A1
Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma

F Millot, A Robert, Y Bertrand, F Mechinaud, Genevieve Laureys (UGent) , A Ferster, P Brock, P Rohrlich, F Mazingue, D Plantaz, et al.

(1997) PEDIATRICS. 100(1). p.60-64

← Previous

Academic Bibliography

Reversion of Autoimmune Lymphoproliferative Syndrome with an anti malaria drug: Clinical and molecular observations

Treatment outcome in infant acute lymphoblastic leukemia.

Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 Randomized Phase III Trial.

Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report.

P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia : results of a 6-year prospective study

The Belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor

Hematopoietic stem cell transplantation in sickle-cell anemia.

Primary immune deficiencies in Belgium.

Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.

Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma

Contents

Support

Contact